As far as funded day shelters, no, those are the two regions at this point in time. Thank you, Mr. Chair.

Thank you, Minister. Mr. Thompson.

Thank you. Just final follow-up, is the department looking at expanding this to the other regions if there are day shelters that are in operation? Thank you.

Thank you, Mr. Thompson. Minister.

Thank you, Mr. Chair. We're always keeping our eyes and ears open. The MLA is certainly going to share thoughts from his region. If it looks like there's an increase in demand, we're open to having those discussions, but it also depends on what's also available in the community where people could be safe and warm during the day. Thank you, Mr. Chair.

Thank you, Minister. Mr. Thompson.

No. Thank you, Mr. Chair. I thank the Minister for that clarification.

Thank you, Mr. Thompson. Are there further comments or questions on community social programs, operations expenditure summary. Seeing none, I'll call the page. Community social programs, operations expenditure summary. Total activity, $27,418,000.

We will now move on to diagnostic and therapeutic services. We will defer the total at the operation expenditure summary on page 192 and discuss the detail on page 193. Comments or questions on page 193. Seeing no comments or question. We will return to page 192. Comments or questions on the operation expenditure summary. Mr. Testart.

Thank you, Mr. Chair. I note that pharmacy spending has decreased by a little more than a million dollars since 2014-15. Can the Minister comment on that reduction? Is it savings found through efficiencies or has there been a change in the cost of pharmaceuticals? Thank you, Mr. Chair.

Thank you, Mr. Testart. Minister.

Thank you. Thank you, Mr. Chair. There have been some changes in the referred-out lab services in the Northwest Territories. There has also been a change in demand of blood and blood products that have lapsed traditionally. As a result, we have reduced our budget to be more consistent with our actuals. Thank you, Mr. Speaker.

Thank you, Minister. Mr. Testart.

Nothing further, Mr. Chair.

Thank you, Mr. Testart. Mr. O'Reilly.

Thanks, Mr. Chair. I'm looking at the diagnostic services line here, and there's fairly substantial reduction of over $300,000 from 2015-16 to 2016-17. Can the Minister or his staff help explain the reductions there? Thanks, Mr. Chair.

Thank you, Mr. O'Reilly. Minister.

Thank you, Mr. Chair. I'll have to go back to Mr. Testart's question because I gave him the answer with the wrong one. Sorry about that.

The changes in this particular line are there are some increases in northern allowance. We had some increase in supplies of about $219,000, and then the answer I give Mr. Testart, which was not the answer he was supposed to get, is we actually had a reduced usage of blood and blood products of about $650,000. We reduced that to be more consistent with our actuals. Thank you, Mr. Chair.

Minister, you want to direct--Minister Abernethy.

Thank you, and to bring clarity to the question Mr. Kieron Testart asked and I give the answer to, the wrong answer, I'll go to Ms. Mathison, please.

Minister Abernethy, are you going to answer Mr. O'Reilly's question?

Thank you, Mr. Chair. I did. I totally answered that one already. Thank you, Mr. Chair.

Mr. O'Reilly, your response to the Minister.

Thanks, Mr. Chair. You look almost as confused as I am. Maybe we could get the Minister to help us get unconfused here. I was talking about the reductions in diagnostic services and he seemed to be talking about blood products, but maybe he can help clarify. Thanks, Mr. Chair.

Minister Abernethy, would you like to clarify Mr. O'Reilly's questions about diagnostic services?